18/10/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

18/10/2024

Oct 18, 2024, 13:54 | Insight
Ruzanna Papyan: Honored to moderate the Young SIOP Education Day session alongside Shushan Hovsepyan
Ruzanna Papyan, Pediatric Oncologist at at the Pediatric Cancer and Blood Disorders Center of Armenia,…
Oct 18, 2024, 13:52 | Insight
Hidehito Horinouchi: Oral Abstract Session 1 at ACLC24
Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X:…
Oct 18, 2024, 13:51 | Insight
Myeloma Paper of the Day, October 18th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Phase 1 first-in-human study of…
Oct 18, 2024, 13:46 | Insight
Highlights from Young SIOP 2024 Day 1
The Young SIOP 2024 is taking place from October 17th - 20th, 2024 in Honolulu,…
Oct 18, 2024, 13:23 | Blog
Prostate cancer spit test could save the NHS £500 million a year - ICR
The Institute of Cancer Research shared on LinkedIn: "NEWS: Prostate cancer spit test could save…
Oct 18, 2024, 12:58 | Blog
Rahul Banerjee: Multicenter description of immune effector cell-associated enterocolitis as a novel toxicity of CAR T-cell therapy in multiple myeloma
Rahul Banerjee shared a post on X, about recent paper published in Blood Cancer Journal:…
Oct 18, 2024, 12:56 | Blog
Jonathan Spicer: Proud of our team’s results in minimally invasive lung resection
Jonathan Spicer, Medical Director of the McGill Thoracic Oncology Program, shared a post on X:…
Oct 18, 2024, 12:22 | Insight
Gustavo Viani: PACE-B supports SBRT as a noninferior option for prostate cancer
Gustavo Viani posted the following on LinkedIn: “PACE-B supports SBRT as a noninferior option for…
Oct 18, 2024, 12:13 | Blog
Miguel Bronchud: Cancer cells reprogrammed into dendritic cells in vivo promote antitumor immunity?
Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared on LinkedIn: "Cancer cells reprogrammed into dendritic cells…
Oct 18, 2024, 12:10 | Blog
From One-Size-Fits-All to Personalized Treatment: An article by Marleen Kok et al.
Maryam Lustberg shared on LinkedIn: "From One-Size-Fits-All to Personalized Treatment: Challenges and Potential Solutions. Opportunities…
All: 79 Posts: 61 - 70
Special Coverage